[Medical care strategy of allergic bronchial asthma and other immunologically-induced lung diseases].
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000542:Alveolitis, Extrinsic Allergic / Q000628:therapy; D001249:Asthma / Q000276:immunology / Q000628:therapy*; D003888:Desensitization, Immunologic; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D010276:Parasympatholytics / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D012130:Respiratory Hypersensitivity / Q000276:immunology / Q000628:therapy*; D013806:Theophylline / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D010276:Parasympatholytics; D011239:Prednisolone; D013806:Theophylline
Betreuungsstrategie bei allergischem Asthma bronchiale und anderen immunologisch bedingten Lungenerkrankungen.